Novartis is an innovative medicines company engaged in the research, development and manufacturing of a broad range of innovative medicines. In 2024, our medicines reached 296 million patients around the world. As a leader in life sciences, we are pursuing innovative approaches to making medicines more affordable and accessible and strengthening our partnerships with communities and society.
Our 2024 Novartis in Society Integrated Report highlights some of the many ways we are contributing to this. Together, we are driving meaningful change to accelerate innovation, expand patient access and create a more inclusive and sustainable healthcare system for all.
